Novagali launches dry eye treatment Cationorm

April 21, 2008

Cationorm, a cationic emulsion to treat dry eye, has been launched in France by Novagali Pharma.

Cationorm, a cationic emulsion to treat dry eye, has been launched in France by Novagali Pharma.

The emulsion, which uses Novasorb technology, acts on the different levels of the tear film. Novasorb, a proprietary platform of Novagali's, uses the electrostatic attraction between the positively charged emulsion and the negatively charged cells of the ocular surface, including cornea and conjunctiva.

Cationorm combines lubricating and hydrating properties to replenish the tear film lipid layer and prevent tear evaporation. Clinical studies have proven the efficacy of Cationorm in treating dry eye symptoms, and it is associated with increased tolerance and comfort.